Ligand · E16
E16 · (4R)-3-[(2S,3S)-3-[[(2S)-2-[[(2S)-2-azanyl-2-phenyl-ethanoyl]amino]-3,3-dimethyl-butanoyl]amino]-2-hydroxy-4-phenyl-but anoyl]-N-[(2R)-3,3-dimethylbutan-2-yl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide
E16, (4R)-3-[(2S,3S)-3-[[(2S)-2-[[(2S)-2-azanyl-2-phenyl-ethanoyl]amino]-3,3-dimethyl-butanoyl]amino]-2-hydroxy-4-phenyl-but anoyl]-N-[(2R)-3,3-dimethylbutan-2-yl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide (C36 H53 N5 O5 S, 667.9 g/mol)…
- Component
- E16
- Formula
- C36 H53 N5 O5 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
E16 in 2 structures; the first of them:
- 3LIV · crystal structure of HTLV protease complexed with the inhibitor KNI-10683 · E16 B117 · binds ARG10, ASP32, GLY34, ALA35, ASP36, MET37, VAL39, VAL56 and 22 more
- 3LIV · Crystal structure of HTLV protease complexed with the inhibitor kni- 10683 · E16 B117 · binds ARG10, ASP32, GLY34, ALA35, ASP36, MET37, VAL39, VAL56 and 22 more
Residues it binds most
LEU 2, ALA 2, ASP 2, GLY 2, VAL 2, ARG 2, ILE 2, MET 2, TRP 2, PHE 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.